Skip to content

FDA decision: Vamikibart by Genentech (on or before July 31, 2027)

Markets

  • What will the FDA's decision be on Vamikibart by Genentech on or before July 31, 2027?

    • Yes50%
    • No50%

    Volume $0 · Liquidity $0

Resolution rules

If the FDA's decision on Vamikibart by Genentech on or before July 31, 2027 is a full approval or an accelerated approval, the market resolves to Yes.

How to read these odds

Each price runs from $0 to $1 and can be read as the probability the market assigns to an outcome: $0.62 means roughly 62%. Prices move with every trade, so they are a crowd estimate, not a guarantee. Before trading, check the resolution rules above, the volume and the liquidity, and only risk money you can afford to lose.

Probability calculators · Glossary · Free courses